title: [Pharmacological properties and clinical efficacy of abatacept (Orencia(®)) for the treatment of rheumatoid arthritis].
authors.affiliation: yuka.yasuoka@bms.com
authors.forename: Yuka
authors.initials: Y
authors.lastname: Yasuoka
authors.forename: Arata
authors.initials: A
authors.lastname: Goto
authors.forename: Taku
authors.initials: T
authors.lastname: Seriu
mesh_terms: D000069594:Abatacept; D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D015703:Antigens, CD; D018501:Antirheumatic Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D060908:CTLA-4 Antigen; D017321:Clinical Trials, Phase I as Topic; D016207:Cytokines / Q000096:biosynthesis; D006801:Humans; D018796:Immunoconjugates / Q000494:pharmacology* / Q000627:therapeutic use*; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D008213:Lymphocyte Activation
chemical_list: D015703:Antigens, CD; D018501:Antirheumatic Agents; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D016207:Cytokines; D018796:Immunoconjugates; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D000069594:Abatacept